The past 20 years have seen the gradual launch of advanced therapy medicinal products (ATMPs), in the EU, presenting patients with treatment options where, in some cases, no previous treatments were available. This pace in innovation is not expected to slow down, with five gene… read more
Sounds of Science Podcast – Episode 14 Trans-Atlantic Innovation : Building bridges between the EU and US life sciences industry With the passing of the Inflation Reduction Act, significant changes are coming for drug pricing and payment in the United States. At the same time,… read more
Sounds of Science Podcast – Episode 13 Rare Disease Day 2023: Improving equitable access and diagnosis for people living with a rare disease Between 27 and 36 million Europeans experience living with a rare disease. Every Rare Disease Day – taking place on 28 February… read more
Sounds of Science – Episode 12 The new EU HTA Procedure: Getting it right to improve patients’ access to innovative therapies With the entry into force of the EU HTA Regulation in January 2022, the European Commission and EUnetHTA21, a consortium of Member States HTA… read more
Sounds of Science – Episode 11 2022 Year in Review: Our Policy team’s perspectives on the past year in EU Health and a look ahead to 2023 Throughout 2022, there have been successes, challenges, delays and change within the European pharmaceutical industry and we expect… read more
The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and European Federation of Pharmaceutical Industries and Associations (EFPIA) have concerns on the current direction of the implementation of the EU HTA Regulation. We are firmly convinced that the input from patient organizations, healthcare professionals, industry and HTA experts and… read more
On 13 October 2022, Alexion held a high-level conference, as part of the “Rare Conversations” event series, on rare disease policies at the Bibliotheque Solvay in Brussels. Alexion’s recent conference in Brussels, Rare Disease Policies 2022, was an insightful look into the possibilities for the… read more
Sounds of Science Podcast – Episode 9 Advanced Therapy Medicinal Products (ATMPs): How they will be impacted by the General Pharmaceutical Legislation On our latest episode, we explore the topic of Advanced Therapy Medical Products, or ATMPs. This covers a wide range of therapies, but… read more
On September 5, 2022, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and Bundesverband der Pharmazeutischen Industrie (BPI) organised an online event on the revision of the EU regulatory framework for orphan drugs and its impact on Germany. The upcoming revision was discussed together with patient… read more
Sounds of Science Podcast – Episode 8 Ensuring a Robust European Health Data Space (EHDS) On 3 May 2022, the European Commission published the proposal for a regulation introducing the European Health Data Space (or EHDS). The proposal aims to enable better exchange and access… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View